HERSHBERG ROBERT
SEC Form 4 insider trading activity
HERSHBERG ROBERT has filed 6 SEC Form 4 filings (11 transaction rows) across 3 companies, including RXRX, ADPT, ATAI, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, HERSHBERG ROBERT is listed as Director at RECURSION PHARMACEUTICALS, INC. Inside the rolling window, HERSHBERG ROBERT reported no open-market purchases and 4 open-market sales totaling $1.7M in RXRX and ADPT and ATAI. The largest disclosed transaction in the window is a sale of 30,664 ADPT shares on Aug 18, 2026, worth $748K.
Companies traded
Other insiders at RXRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HERSHBERG ROBERT made?
HERSHBERG ROBERT has filed 6 SEC Form 4 filings (11 transaction rows) across 3 companies, including RXRX, ADPT, ATAI since 2025.
Which companies does HERSHBERG ROBERT trade?
HERSHBERG ROBERT has filed SEC Form 4 disclosures for 3 companies, including RXRX, ADPT, ATAI.
When was HERSHBERG ROBERT's most recent SEC Form 4 filing?
HERSHBERG ROBERT's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is HERSHBERG ROBERT's total buy and sell value in the current window?
Inside the rolling retention window, HERSHBERG ROBERT bought $0 and sold $1.7M based on SEC Form 4 filings.
What was HERSHBERG ROBERT's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,664 ADPT shares on 2026-08-18, worth $748K, per SEC Form 4 filings.